Impact of metabolic syndrome on the outcome of patients with stable coronary artery disease: 2-year follow-up of the MASS II study

Neuza Lopes(Universidade de São Paulo), Whady Hueb(Universidade de São Paulo), Alexandre C. Pereira(University of Washington), Cibele Larrosa Garzillo(Universidade de São Paulo), Noedir Antônio Groppo Stolf, Antônio Ricardo de Toledo Gagliardi(Universidade de São Paulo), Felipe S. Paulitsch(Universidade de São Paulo), João Ferreira(Universidade de São Paulo), Aécio Flávio Teixeira de Góis(Universidade de São Paulo)
Coronary Artery Disease
September 1, 2008
10.1097/mca.0b013e328306aa8a
Cited by 17

Related Papers

Transfusion Requirements After Cardiac Surgery
|JAMA|2010|1k
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy
|Circulation|2018|837
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials
|The Lancet|2009|746
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data
|The Lancet|2018|733
Five-Year Follow-Up of the Medicine, Angioplasty, or Surgery Study (MASS II)
|Circulation|2007|582